CIPLA CINACALCET cinacalcet (as hydrochloride) 60 mg tablet bottle

מדינה: אוסטרליה

שפה: אנגלית

מקור: Department of Health (Therapeutic Goods Administration)

מרכיב פעיל:

cinacalcet hydrochloride, Quantity: 66.128 mg (Equivalent: cinacalcet, Qty 60 mg)

זמין מ:

Cipla Australia Pty Ltd

טופס פרצבטיות:

Tablet, film coated

הרכב:

Excipient Ingredients: microcrystalline cellulose; pregelatinised starch; crospovidone; povidone; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; indigo carmine aluminium lake

מסלול נתינה (של תרופות):

Oral

יחידות באריזה:

28's

סוג מרשם:

(S4) Prescription Only Medicine

סממני תרפויטית:

Cipla Cinacalcet may be used to treat the biochemical manifestations of secondary hyperparathyroidism (HPT) in patients with end stage renal disease, receiving dialysis (see section 5.1 Pharmacodynamic properties, Clinical trials). Cipla Cinacalcet should be used as adjunctive therapy.,Cipla Cinacalcet is indicated for the treatment of hypercalcaemia in patients with parathyroid carcinoma.,Cipla Cinacalcet may be used to treat the biochemical manifestations of primary HPT in patients for whom parathyroidectomy is not a treatment option.

leaflet_short:

Visual Identification: Light green coloured, oval shaped, biconvex film-coated tablets, debossed with "CL" on one side and "411" on other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

מצב אישור:

Registered

תאריך אישור:

2023-02-07